Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > restructure point was 15,21$, anything u can get below that

<< Previous

Bullboard Posts

Next >>

Comment by PLITheOneon Apr 17, 2020 1:20pm

101 Views

Post# 30922714

RE:restructure point was 15,21$, anything u can get below that

You are so WRONG! People should not be listening to you!
You shouldn’t be listening to you!
Fact is their cost was reduced far below 15.21 a share.
Oh did you forget, not understand, didn’t realize $120M was stolen from shareholders after beating down the share price so they could maximize stealing greater ownership.
You come across as a fool Newcamo.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal